Wordt geladen...
Spotlight on brodalumab in the treatment of plaque psoriasis: the evidence to date
The IL-17/IL-23 axis is now understood to influence psoriasis, and the development of novel IL-17 inhibitor medications marks a sea change in the treatment of psoriasis. Brodalumab is a recombinant, fully human immunoglobulin IgG2 monoclonal antibody specifically targeted against IL-17RA. This artic...
Bewaard in:
| Gepubliceerd in: | Clin Cosmet Investig Dermatol |
|---|---|
| Hoofdauteurs: | , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6503649/ https://ncbi.nlm.nih.gov/pubmed/31118733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CCID.S165605 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|